Overview
Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia.
Indication
用于治疗高血压；尚可用于良性前列腺增生肥大；注射剂主要用于术中高血压危象。
Associated Conditions
- Hypertension
- Hypertensive Emergency
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/10/10 | N/A | Not yet recruiting | Qianfoshan Hospital | ||
2019/01/02 | Phase 3 | Completed | The George Institute for Global Health, China | ||
2018/04/13 | Not Applicable | Completed | Chinese PLA General Hospital | ||
2017/10/03 | Phase 4 | Withdrawn | |||
2016/12/23 | Phase 1 | UNKNOWN | |||
2016/08/05 | Not Applicable | UNKNOWN | Hu Anmin | ||
2015/09/23 | Phase 3 | Terminated | University Hospital, Strasbourg, France | ||
2011/03/09 | Not Applicable | Withdrawn | University Hospital Schleswig-Holstein | ||
2006/12/08 | Phase 3 | UNKNOWN | University Hospital, Strasbourg, France | ||
2005/09/26 | Not Applicable | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Urapidil and Glucose Injection | 国药准字H20041110 | 化学药品 | 注射剂 | 3/5/2020 | |
| Urapidil Sustained-release Tablets | 国药准字H20000463 | 化学药品 | 片剂 | 10/14/2020 | |
| Urapidil Sustained-release Tablets | 国药准字H20051293 | 化学药品 | 片剂(缓释片) | 7/16/2020 | |
| Urapidil Injection | 国药准字H20040501 | 化学药品 | 注射剂 | 10/13/2020 | |
| Urapidil Injection | 国药准字H20020288 | 化学药品 | 注射剂 | 10/9/2020 | |
| Urapidil Injection | 国药准字H20010587 | 化学药品 | 注射剂 | 8/11/2020 | |
| Urapidil Injection | 国药准字H20010473 | 化学药品 | 注射剂 | 7/28/2021 | |
| Urapidil Injection | 国药准字H20010806 | 化学药品 | 注射剂 | 5/15/2020 | |
| Urapidil Hydrochloride Injection | 国药准字H20233176 | 化学药品 | 注射剂 | 2/14/2023 | |
| Urapidil Hydrochloride Injection | 国药准字H20253323 | 化学药品 | 注射剂 | 1/24/2025 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.